Cystic fibrosis: Exploiting its genetic basis in the hunt for new therapies
- 28 February 2010
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 125 (2), 219-229
- https://doi.org/10.1016/j.pharmthera.2009.10.006
Abstract
No abstract availableKeywords
This publication has 135 references indexed in Scilit:
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770Proceedings of the National Academy of Sciences, 2009
- Cystic fibrosisThe Lancet, 2009
- Transduction Efficiencies of Novel AAV Vectors in Mouse Airway Epithelium In Vivo and Human Ciliated Airway Epithelium In VitroMolecular Therapy, 2009
- One step at a time: endoplasmic reticulum-associated degradationNature Reviews Molecular Cell Biology, 2008
- Expression Cloning of TMEM16A as a Calcium-Activated Chloride Channel SubunitCell, 2008
- Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceJournal of Cystic Fibrosis, 2008
- Phenylalanine-508 mediates a cytoplasmic–membrane domain contact in the CFTR 3D structure crucial to assembly and channel functionProceedings of the National Academy of Sciences, 2008
- PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR -G542X nonsense allele in a CF mouse modelProceedings of the National Academy of Sciences, 2008
- Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministeredProceedings of the National Academy of Sciences, 2006
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995